ZOLL Executive and Leadership Team

Eric Knudsen, the Chief Executive Officer at ZOLL, directs the overarching strategic vision for the organization. Knudsen architects long-term growth initiatives by aligning medical device innovation with the evolving needs of global healthcare providers. Overseeing the entire corporate structure, the Chief Executive Officer ensures that all departments maintain a unified focus on cardiopulmonary and respiratory treatment advancements. This leadership role involves constant collaboration with the Board to refine market positioning and expand the reach of life-saving technologies across North America, Europe, and Asia. By prioritizing research and development, Eric Knudsen drives the company toward sustained excellence in the competitive medical manufacturing sector. Ultimately, the Chief Executive Officer secures the operational stability required to deliver high-quality monitoring systems and defibrillators to critical care facilities worldwide.

Walter Hall, the Vice President Finance and Admin and Chief Financial Officer at ZOLL, manages the fiscal health and administrative infrastructure of the organization. Hall directs capital allocation strategies to support ongoing research into cardiopulmonary treatment technologies. Overseeing financial reporting and internal controls, the Chief Financial Officer ensures transparency and regulatory compliance across all global operations. This leadership role involves analyzing revenue streams from medical device sales to optimize profitability and resource distribution. By providing data-driven insights, Walter Hall supports the executive team in making informed decisions regarding market expansion and product development. The Vice President Finance and Admin and Chief Financial Officer maintains a focus on long-term financial sustainability, enabling the company to invest in cutting-edge medical innovations that improve patient care in critical situations.

Sean Rollman, the Chief Financial Officer & Zoll Site Leader (Pittsburgh) & Vice President, Operations & Services at ZOLL, oversees the operational and financial performance of the Pittsburgh facility. Rollman directs the service delivery models that support the maintenance and deployment of life-saving medical equipment. Overseeing site-specific operations, the Chief Financial Officer & Zoll Site Leader (Pittsburgh) & Vice President, Operations & Services ensures that manufacturing processes remain efficient and compliant with industry standards. This leadership role involves managing the financial budget for regional services while optimizing the supply chain for critical care devices. By aligning operational output with financial targets, Sean Rollman drives the company's ability to provide consistent support to healthcare providers. The Chief Financial Officer & Zoll Site Leader (Pittsburgh) & Vice President, Operations & Services maintains a focus on operational excellence to ensure the reliability of all medical technologies.

Osnat Gat, the Chief Operating Officer (Israel) at ZOLL, directs the internal scaling and manufacturing logistics within the Israeli operations. Gat manages the production workflows for advanced medical devices, ensuring that quality control measures remain robust during high-volume manufacturing. Overseeing the daily operations of the facility, the Chief Operating Officer (Israel) coordinates with global supply chain teams to maintain the steady flow of components for defibrillators and monitoring systems. This leadership role involves implementing process improvements to increase manufacturing efficiency and reduce lead times for healthcare providers. By focusing on operational precision, Osnat Gat drives the company's ability to meet the global demand for critical care technology. The Chief Operating Officer (Israel) ensures that all production activities align with the company's overarching mission to deliver reliable, life-saving equipment to medical professionals worldwide.

Shiri Shneorson, the President, ZOLL Itamar at ZOLL, leads the specialized division focused on respiratory and sleep diagnostic technologies. Shneorson directs the strategic growth of the Itamar product line, ensuring that innovative monitoring solutions reach clinical markets effectively. Overseeing the division's research and commercialization efforts, the President, ZOLL Itamar ensures that diagnostic tools provide accurate data for treating cardiopulmonary conditions. This leadership role involves collaborating with healthcare providers to integrate new respiratory monitoring systems into standard clinical practice. By driving market adoption, Shiri Shneorson expands the company's footprint in the diagnostic sector. The President, ZOLL Itamar maintains a focus on technological advancement and clinical efficacy, ensuring that the division contributes significantly to the company's mission of improving patient outcomes through specialized medical technology and innovative diagnostic services.

Michael Blastick, the President, Zoll Cardiac Management Solutions at ZOLL, directs the commercial strategy for cardiac monitoring and management services. Blastick oversees the deployment of advanced software and hardware solutions that assist healthcare providers in managing patient cardiac health. Coordinating with sales and clinical teams, the President, Zoll Cardiac Management Solutions ensures that cardiac management tools are effectively utilized in critical care settings. This leadership role involves analyzing market needs to refine the service portfolio and enhance the value provided to medical institutions. By driving the adoption of cardiac management technologies, Michael Blastick supports the company's goal of improving patient outcomes through continuous monitoring. The President, Zoll Cardiac Management Solutions maintains a focus on operational growth and service excellence, ensuring that the division remains a key component of the company's comprehensive medical technology ecosystem.

Efrat Litman, the Chief Technology Officer at ZOLL, leads the research and development division focused on next-generation medical devices. Litman architects the technical roadmap for automated external defibrillators and advanced monitoring software. Overseeing engineering teams, the Chief Technology Officer ensures that all product designs meet rigorous safety and performance standards for critical care environments. This leadership role involves bridging the gap between clinical requirements and technological implementation to enhance patient outcomes. By fostering a culture of innovation, Efrat Litman drives the development of proprietary diagnostic tools that define the company's market position. The Chief Technology Officer collaborates with cross-functional leaders to integrate new software solutions into existing hardware platforms. Through continuous technical refinement, Litman maintains the company's status as a leader in medical technology manufacturing.

Uriel Weinstein, the General Manager and Chief Technology Officer at ZOLL, manages the intersection of operational performance and technical innovation. Weinstein directs the development of specialized software solutions designed to enhance the efficacy of cardiopulmonary diagnostic equipment. Overseeing the integration of new technologies into the existing product portfolio, the General Manager and Chief Technology Officer ensures that engineering outputs align with the company's broader mission of improving patient outcomes. This role involves coordinating with manufacturing teams to streamline the production of complex medical devices. By leveraging technical expertise, Uriel Weinstein drives efficiency in the development lifecycle, ensuring that advanced monitoring systems reach healthcare providers rapidly. The General Manager and Chief Technology Officer maintains a focus on scaling technical capabilities to meet the growing demand for high-quality critical care equipment across global regions.

Bailey Rey, the Managing Director at ZOLL, oversees regional market expansion and operational execution. Rey manages the integration of medical device distribution networks to ensure consistent product availability for healthcare providers. Coordinating with international teams, the Managing Director drives efficiency across diverse geographic territories, including North America and emerging global markets. This role involves optimizing supply chain logistics to support the deployment of advanced life support equipment. By analyzing regional market trends, Bailey Rey identifies opportunities for scaling the presence of monitoring systems in critical care settings. The Managing Director maintains strict adherence to quality standards while fostering relationships with key stakeholders. Through these efforts, Rey strengthens the company's ability to provide essential respiratory and cardiopulmonary solutions to medical professionals on a global scale.